Search Results - Knut Wendelin
- Showing 1 - 2 results of 2
-
1
First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany by Theo Leitner, Cyrus Khandanpour, Cyrus Khandanpour, Knut Wendelin, Fuat Oduncu, Christoph Kimmich, Ralph Naumann, Miriam Kull, Hartmut Goldschmidt, Martin Ehmer, Claudia Kiewitz, Hans Salwender
Published in Frontiers in Hematology (2024-06-01)Get full text
Article -
2
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia by Nicola Gökbuget, Kristina Ihrig, Michael Stadler, Matthias Stelljes, Ahmet Elmaagacli, Michael Starck, Simon Raffel, Andrea Stoltefuss, Andreas Viardot, Karl-Anton Kreuzer, Daniela Heidenreich, Andrea Renzelmann, Ralph Wäsch, Max S. Topp, Barbara Ritter, Peter Reimer, Joachim Beck, Jörg Westermann, Knut Wendelin, Nael Alakel, Maher Hanoun, Hubert Serve, Dieter Hoelzer
Published in Haematologica (2023-02-01)Get full text
Article
